| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
40,876 |
36,851 |
$2.76M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,313 |
15,169 |
$1.01M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,978 |
7,441 |
$698K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,977 |
1,932 |
$170K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,480 |
1,425 |
$120K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,159 |
1,135 |
$99K |
| 90686 |
|
4,476 |
4,416 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
282 |
275 |
$26K |
| 96127 |
|
5,244 |
4,387 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
234 |
223 |
$8K |
| 99215 |
Prolong outpt/office vis |
61 |
57 |
$8K |
| 90837 |
Psychotherapy, 53 minutes with patient |
84 |
63 |
$8K |
| 90480 |
|
214 |
212 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
448 |
412 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
129 |
126 |
$5K |
| 0072A |
|
118 |
118 |
$5K |
| 0071A |
|
105 |
105 |
$4K |
| 99177 |
|
939 |
925 |
$4K |
| 90670 |
|
445 |
435 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
579 |
472 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
91 |
89 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
175 |
86 |
$3K |
| 90688 |
|
272 |
258 |
$2K |
| 91321 |
|
94 |
94 |
$2K |
| 90651 |
|
134 |
130 |
$1K |
| 90685 |
|
137 |
136 |
$1K |
| 90647 |
|
140 |
139 |
$1K |
| 90633 |
|
136 |
129 |
$1K |
| 90680 |
|
115 |
114 |
$1K |
| 90723 |
|
115 |
115 |
$989.42 |
| 91322 |
|
39 |
38 |
$764.20 |
| 99173 |
|
427 |
409 |
$620.08 |
| 96161 |
|
264 |
258 |
$599.46 |
| 0074A |
|
14 |
14 |
$560.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
97 |
91 |
$441.49 |
| 90716 |
|
38 |
38 |
$288.08 |
| 90656 |
|
76 |
76 |
$282.10 |
| 90697 |
|
26 |
25 |
$209.00 |
| 90734 |
|
13 |
12 |
$118.60 |
| 90671 |
|
14 |
13 |
$100.79 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
293 |
277 |
$40.00 |
| 96160 |
|
33 |
30 |
$38.58 |
| 85018 |
|
15 |
12 |
$29.76 |
| 36416 |
|
15 |
12 |
$28.30 |
| 99072 |
|
821 |
777 |
$0.00 |
| 99070 |
|
52 |
52 |
$0.00 |
| 90667 |
|
26 |
25 |
$0.00 |